Early in tumorigenesis, an ‘angiogenic switch’ occurs within the tumour microenviro nment, which is associated with the altered expression of a range of proangiogenic growth factors, such as vascular endothelial growth factor-A (VEGF) and basic fibroblast growth factor (bFGF). This evidence concerns the gene FGF2 and neoplasm.